The Newcastle upon Tyne Hospitals NHS Foundation Trust recently published, “Clinical trial hopes to predict response to cancer treatment”, which highlights iPREDICT clinical trial and CD8 ImmunoPET ™.
Read what Dr. Rachel Pearson from the Northern Center for Cancer Care says about cancer research and for the first time hear from patient, Robert Charlton’s and his experience as a participant in the iPREDICT clinical trial.
Clinical trial hopes to predict response to cancer treatment
